Lumida
/OLPX
⌘K
Olaplex Holdings Inc

Olaplex Holdings Inc

OLPX
$2.07USD+0.00%+0.00 today

MARKET CAP

1.4B

P/E (TTM)

FWD P/E

DAY RANGE

$2 – $2

52W RANGE

$2$2

AI Summary

Stalk
Sell NowMedium

Price has clustered at the $2.05 resistance zone in a Stage 3 distribution, showing multiple Bullish Exhaustion signals and extreme overbought conditions, indicating weakening demand. With EMAs flattening overhead and volume diminishing on advances, the structure favors a pullback or reversal. Medium-term distribution risk and lack of mean reversion support reinforce a bearish tradable side. Short-term timing aligns for sell-side execution into the resistance cluster.

  • Net sales reached $106.3M in Q2 2025, up 0.3% YoY amid transformation.
  • Launched Scalp Longevity Treatment, enhancing innovation pipeline.
  • Professional channel sales declined 10.9% in Q3 2025, signaling execution risks.
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

Olaplex Holdings Inc. (NASDAQ: OLPX) is a leading player in the beauty and personal care industry, particularly specializing in innovative hair care products that utilize advanced bond-building technology. The company targets both professional salons and the direct-to-consumer market, driving its growth through a strong scientific foundation and a focus on consumer health and wellness trends. Olaplex is currently undergoing a transformative period, adjusting its brand identity and operational strategies to capitalize on the increasing demand for premium beauty solutions.

Bull says

  • Net sales reached $106.3M in Q2 2025, up 0.3% YoY amid transformation.
  • Launched Scalp Longevity Treatment, enhancing innovation pipeline.
  • Professional channel sales grew 5.3% to $44.5M in Q3 2025 after marketing reset.
  • Ended Q2 2025 with $289.3M cash and sustained positive free cash flow.
  • Refreshed marketing drove a 7% rise in brand awareness and engagement.
  • Solid leverage and liquidity, moderate momentum factors, oil-price tailwinds.

Bear says

  • Professional channel sales declined 10.9% in Q3 2025, signaling execution risks.
  • Adjusted EBITDA margin contracted to 22.2% in Q4 2025 versus 30.7% a year ago.
  • SG&A expenses rose to $54.3M in Q2 2025, pressuring margins.
  • Management warned of uncertain consumer sentiment into the holiday season.
  • Forecasts suggest net sales may drop up to 3% YoY in 2026.
  • Weak earnings yield and profitability factors, negative growth outlook, high short interest.

Earnings Call · Q4 2024 · Mgmt. Guidance

Updated 07-02-2026neutral

Transcript signals

Bull points

  • In fact, while we continue to have work to do on our international strategy, our international results were better than expected.
  • Overall, we are encouraged to see this progress.
  • Specialty retail had an encouraging performance with Q4 sales up 5.7% to 28.8 million compared to the fourth quarter of 2023.

Bear points

  • decreased 2.5% versus a year ago, with year-over-year growth at olaplex.com offset by strategic international rationalization.
  • our professional channel sales declined 27.1% year-over-year, with the channel seeing a greater impact from our focus on partnering with fewer but stronger international distributors that are aligned with our brand values and softer sell-in across geographies.
  • 2024 was a productive year in moving us towards that goal. We started to harness our innovation and marketing capabilities, as well as implemented important work streams to connect with our partners across the globe, strengthen our business processes, and attract talented executives to our team.
Read full transcript analysis ›